Arvinas, Inc. (ARVN)
11.00
0.00 (0.00%)
USD |
NASDAQ |
Apr 17, 16:00
10.98
-0.02
(-0.14%)
After-Hours: 20:00
Arvinas Cash from Investing (Quarterly) : 145.80M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Pfizer Inc. | -6.146B |
| EyePoint, Inc. | -74.67M |
| Apellis Pharmaceuticals, Inc. | -0.108M |
| Elanco Animal Health, Inc. | -64.00M |
| Gossamer Bio, Inc. | 73.16M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -30.40M |
| Cash from Financing (Quarterly) | -74.00M |
| Free Cash Flow | -275.70M |
| Free Cash Flow Per Share (Quarterly) | -0.4715 |
| Free Cash Flow to Equity (Quarterly) | -30.20M |
| Free Cash Flow to Firm (Quarterly) | -30.60M |
| Free Cash Flow Yield | -35.33% |